KOMRILU Trademark

Trademark Overview


On Monday, January 13, 2020, a trademark application was filed for KOMRILU with the United States Patent and Trademark Office. The USPTO has given the KOMRILU trademark a serial number of 79280370. The federal status of this trademark filing is REGISTERED as of Tuesday, August 11, 2020. This trademark is owned by Glaxo Group Limited. The KOMRILU trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
komrilu

General Information


Serial Number79280370
Word MarkKOMRILU
Filing DateMonday, January 13, 2020
Status700 - REGISTERED
Status DateTuesday, August 11, 2020
Registration Number6121500
Registration DateTuesday, August 11, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 26, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 9, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Friday, July 28, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, December 12, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, November 24, 2020FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, November 24, 2020FINAL DISPOSITION PROCESSED
Wednesday, November 11, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 11, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, May 26, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 26, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 6, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, April 18, 2020REFUSAL PROCESSED BY IB
Friday, April 17, 2020ASSIGNED TO LIE
Wednesday, April 8, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 7, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 7, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 7, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, March 28, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, March 28, 2020REFUSAL PROCESSED BY MPU
Thursday, March 19, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, March 18, 2020NON-FINAL ACTION WRITTEN
Sunday, March 15, 2020ASSIGNED TO EXAMINER
Friday, March 13, 2020APPLICATION FILING RECEIPT MAILED
Monday, March 9, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 5, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB